Quartesian’s medical writing team has extensive experience in Protocol Development, PK/PD Report, Clinical Summary Report, Abstracts, Posters and Manuscripts.
Quartesian has vast experience in Clinical Protocol Development. Our technical team works closely with the client/sponsor to develop the protocol which accurately describes the objective, rationale, design, methodology and organization of the proposed clinical study. We ensure that the protocol adheres to Good Clinical Practice (GCP) guidelines, as well as all federal and local regulations.
We also offer our clients study design consultation. Our team has an excellent experience in providing optimal designs for Phase-I – IV clinical studies and also for large scale Registry, Observational and Health Economics studies.
Depending on your preference, Quartesian will be willing to be associated fully or partly in your clinical study design and protocol development activities.
Quartesian boasts of a highly skilled team of Clinical Pharmacokineticists, Biostatisticians, and Technical Writers committed to providing high-quality, regulatory-compliant PK/PD reporting. Quartesian has writing capabilities to support individual PK/PD reports, and PK sections of Clinical Summary Reports for regulatory submission.
Clinical Summary Report
Quartesian’s team of experienced medical writers possess extensive expertise in developing high quality clinical summary reports for phase I-IV, Registry, Observational and health economics studies.
Our team has a proven track record of successfully developing numerous highest quality Clinical Summary Reports in the most cost-efficient and timely manner.
Abstracts, Posters and Manuscripts
Quartesian also has extensive experience in the development of the following:
- Manuscripts and White Papers
- Posters and Presentations
We have developed numerous abstracts, manuscripts and posters for phase I-IV, Registry, Observational and Health Economics Studies. The abstracts, manuscripts and posters developed by us have been submitted to FDA and European regulatory authorities and also been displayed in various conferences and meetings all over the World.